Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
64 hedge funds and large institutions have $23.7M invested in Ampio Pharmaceuticals Inc. in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 26 closing their positions.
71% more call options, than puts
Call options by funds: $859K | Put options by funds: $503K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 75 → 64 (-11)
22% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 18
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
75% less capital invested
Capital invested by funds: $95.5M → $23.7M (-$71.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.16M |
| 2 |
Millennium Management
New York
|
+$621K |
| 3 |
Goldman Sachs
New York
|
+$383K |
| 4 |
NFG
Noven Financial Group
Denver,
Colorado
|
+$322K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$306K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$3.67M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$2.88M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.82M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.38M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.33M |
AMPE Hedge Fund Activity: Q2 2015 in Review
64 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2015, worth a combined $23.7M — down 75% from $95.5M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AMPE and 15 opened new positions — a net loss of 11 holders — while 18 trimmed existing stakes and 14 added.
The largest buyer was Susquehanna International Group, adding an estimated $1.16M. The largest seller was BlackRock Fund Advisors, cutting an estimated $3.67M.
- 64 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2015, down from 75 in Q1 2015.
- Funds reported $23.7M of Ampio Pharmaceuticals Inc. stock for Q2 2015, down 75% quarter-over-quarter.
- 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2015 and 26 closed out, a net change of -11 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2015 was Susquehanna International Group, an estimated $1.16M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2015 was BlackRock Fund Advisors, an estimated $3.67M sold.
Based on aggregated 13F filings for Q2 2015.